The global ancestry testing market is expected to grow at a significant CAGR during the forecast period (2021-2027). Ancestry testing, often known as genetic genealogy, is a technique for determining a person's ancestral relationship by examining their family history (genealogy). DNA variation analysis offers precise information about the forebears' origins. Despite the fact that genealogical DNA tests are not intended for medical use, autosomal DNA testing can be used to assess the risk of hundreds of heritable medical disorders, as genetics plays a significant role in some of them. Physicians may propose primary care and create tailored drugs to treat the disease based on the results of the examination. For instance, haemophilia is a bleeding illness that can be traced back to Queen Victoria, who passed the haemophilia gene to male heirs in royal houses in Russia, Spain, and Germany. The British royal family has used ancestry testing to avoid bleeding accidents. 

In the healthcare industry, ancestral testing is becoming more common as a way to discover any genetic variations before producing tailored treatments. The use of ancestry genetics testing in customized and precision medicine has emerged the pharmacogenomics, which entails optimizing pharmacological therapy for reducing any negative side effects. It also allows doctors to predict the illness using their own DNA profiles. 23andMe is one of the market's leading players that uses a tiny genotyping chip to create genetic blueprints of customers' ancestry, genetic profile, and health characteristics markers, which can be used in scientific research to generate individualized drugs. 

Additionally, methods such as single nucleotide polymorphism, focused analysis, and whole-genome sequencing are used in the ancestry testing sector. SNP testing evaluates a vast number of genetic changes (single nucleotide polymorphisms or SNPs) across an individual's complete genome. Therefore, it is often employed in forensic ancestry to identify suspects or victims in criminal situations. Forensic ancestry testing, such as GEDMatch, has proven the presence of over 40 murder and sexual assault suspects in the US. The FBI has created its own Combined DNA Index System (CODIS) database, which contains forensic genetic profiles of around 18 million people convicted in serial murder and sexual assault cases. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Laboratory Corp. of America Holdings, Helix OpCo, LLC, and Quest Diagnostics Inc., among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Ancestry Testing Market Report Segmentation

By Test Type 

• Carrier Testing

• Predictive Testing

• Ancestry & Relationship Testing

• Nutrigenomic Testing

• Genealogic DNA Testing 

o Y Chromosome Testing

o Mitochondrial DNA Testing

o Autosomal DNA Testing

o Single Nucleotide Polymorphism Testing

By Application 

• Offline 

• Online  

Global Ancestry Testing Market by Region